SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-16-001496
Filing Date
2016-06-16
Accepted
2016-06-16 17:21:20
Documents
2
Group Members
ALEXANDER J. DENNER, PH.D.SARISSA CAPITAL DOMESTIC FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #6 sarissa13da6.htm SC 13D/A 100318
2 VOTING AGREEMENT sarrissaex1.htm EX-1 76687
  Complete submission text file 0000899140-16-001496.txt   178740
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 161718308
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A